Extension Study of Participants From SPG302-ALS-001

Clinical trial NCT06903286 · TERMINATED

Trial details

NCT number: NCT06903286
Sponsor: Spinogenix
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-05-29
Primary completion: 2025-06-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.